These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26306155)

  • 1. Lower Oncogenic Potential of Human Mesenchymal Stem Cells Derived from Cord Blood Compared to Induced Pluripotent Stem Cells.
    Foroutan T; Najmi M; Kazemi N; Hasanlou M; Pedram A
    Int J Organ Transplant Med; 2015; 6(3):99-104. PubMed ID: 26306155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Differentiation of Induced Pluripotent Stem Cells and Bone-Marrow Mesenchymal Stem Cells to Osteoblast: Osteogenesis versus Pluripotency.
    Foroutan T
    Int J Organ Transplant Med; 2016; 7(2):91-96. PubMed ID: 28435641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of OCT4 Gene Expression Upregulation on the Expression of iPSC-related Transcription Factors in Human Bone Marrow Derived Mesenchymal Stem Cells].
    Guo XP; Tang YM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1086-1095. PubMed ID: 32798382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of induced pluripotent stem cells from human mesenchymal stem cells of parotid gland origin.
    Yan X; Xu N; Meng C; Wang B; Yuan J; Wang C; Li Y
    Am J Transl Res; 2016; 8(2):419-32. PubMed ID: 27158336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Stem Cell Subpopulations Are Present Within Metastatic Head and Neck Cutaneous Squamous Cell Carcinoma.
    Kilmister EJ; Patel J; van Schaijik B; Bockett N; Brasch HD; Paterson E; Sim D; Davis PF; Roth IM; Itinteang T; Tan ST
    Front Oncol; 2020; 10():1091. PubMed ID: 32850316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of human-induced pluripotent stem cells from gut mesentery-derived cells by ectopic expression of OCT4/SOX2/NANOG.
    Li Y; Zhao H; Lan F; Lee A; Chen L; Lin C; Yao Y; Li L
    Cell Reprogram; 2010 Jun; 12(3):237-47. PubMed ID: 20698766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue.
    Heo JS; Choi Y; Kim HS; Kim HO
    Int J Mol Med; 2016 Jan; 37(1):115-25. PubMed ID: 26719857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of human induced pluripotent stem cells into erythroid cells.
    Ebrahimi M; Forouzesh M; Raoufi S; Ramazii M; Ghaedrahmati F; Farzaneh M
    Stem Cell Res Ther; 2020 Nov; 11(1):483. PubMed ID: 33198819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of human induced pluripotent stem cell-derived mesenchymal stem cells and umbilical cord mesenchymal stem cells.
    Rajasingh S; Sigamani V; Selvam V; Gurusamy N; Kirankumar S; Vasanthan J; Rajasingh J
    J Cell Mol Med; 2021 Sep; 25(18):8904-8919. PubMed ID: 34390186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous LIN28 Is Required for the Maintenance of Self-Renewal and Pluripotency in Presumptive Porcine-Induced Pluripotent Stem Cells.
    Chakritbudsabong W; Chaiwattanarungruengpaisan S; Sariya L; Pamonsupornvichit S; Ferreira JN; Sukho P; Gronsang D; Tharasanit T; Dinnyes A; Rungarunlert S
    Front Cell Dev Biol; 2021; 9():709286. PubMed ID: 34354993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
    Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
    Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?
    Gunaratne PH
    Curr Stem Cell Res Ther; 2009 Sep; 4(3):168-77. PubMed ID: 19492978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells.
    Bazley FA; Liu CF; Yuan X; Hao H; All AH; De Los Angeles A; Zambidis ET; Gearhart JD; Kerr CL
    Stem Cells Dev; 2015 Nov; 24(22):2634-48. PubMed ID: 26154167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Concise Review on Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Personalized Regenerative Medicine.
    Pushp P; Nogueira DES; Rodrigues CAV; Ferreira FC; Cabral JMS; Gupta MK
    Stem Cell Rev Rep; 2021 Jun; 17(3):748-776. PubMed ID: 33098306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of induced pluripotent stem cells from neural stem cells.
    Kim JB; Zaehres H; Araúzo-Bravo MJ; Schöler HR
    Nat Protoc; 2009; 4(10):1464-70. PubMed ID: 19798081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell Populations Expressing Stemness-Associated Markers in Lung Adenocarcinoma.
    Paterson C; Kilmister EJ; Brasch HD; Bockett N; Patel J; Paterson E; Purdie G; Galvin S; Davis PF; Itinteang T; Tan ST
    Life (Basel); 2021 Oct; 11(10):. PubMed ID: 34685477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospects of induced pluripotent stem cell technology in regenerative medicine.
    Zhang F; Citra F; Wang DA
    Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OCT4, SOX2 and NANOG co-regulate glycolysis and participate in somatic induced reprogramming.
    Ding Y; Yuan X; Zou Y; Gao J; Xu X; Sun H; Zuo Q; Zhang Y; Li B
    Cytotechnology; 2022 Jun; 74(3):371-383. PubMed ID: 35733702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).
    Lee S; Wottrich S; Bonavida B
    Tumour Biol; 2017 Apr; 39(4):1010428317692253. PubMed ID: 28378634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.